Special Issue "Obstructive Sleep Apnea: Epidemiology, Pathomechanism and Treatment"
A special issue of Medicina (ISSN 1010-660X).
Deadline for manuscript submissions: closed (31 January 2020).
Interests: respiratory physiology; respiratory mechanics; asthma; lung; pulmonary medicine; airway obstruction; chronic obstructive pulmonary disease; OSA; pulmonary function test; pneumology; sputum; respiratory immunology; exhaled biomarkers
Interests: chronic obstructive pulmonary disease; asthma; lung diseases; airway obstruction; OSA; spirometry; pulmonary medicine; asthma management; respiration disorders; allergic diseases; sputum; exhaled biomarkers
Obstructive sleep apnea (OSA) is a common disease that may affect up to 50% of the adult population; however, the exact prevalence in different communities is unknown. OSA is associated with the development of cardiometabolic and mood disorders, and cognitive dysfunction. Hence, it leads to impaired quality of life and work performance, car accidents, and heightened morbidity and mortality. Interestingly, factors leading to the development of comorbidities, cognitive impairment and daytime sleepiness are not fully understood. Continuous positive airway pressure (CPAP) is the gold standard treatment and is highly effective in moderate to severe disease cases. The data on the effects of CPAP in mild disease cases, as well as the effects of second-line treatment (i.e., mandibular advancement device, surgical procedures, etc), however, provided much less evidence.
We invite you to contribute an original research or review article on OSA. We are particularly interested in epidemiological studies from countries that have not been represented in previous publications. We are also keen to receive articles dealing with the pathophysiological pathways connecting OSA to comorbidities. Articles on human studies and experimental animal and cell culture models are equally encouraged. Please, do not hesitate to submit the results of clinical trials as well.
Dr. Andras Bikov
Dr. Silvano Dragonieri
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- OSA treatment